Profile
Anne Bowdidge is currently the Head-Investor & Media Relations at Adicet Bio, Inc. and the Head-Investor Relations at AN2 Therapeutics, Inc. Previously, she worked as the Senior Director-Investor Relations at Medivation LLC (California) from 2012 to 2017 and as the Head-Investor & Media Relations at Anthera Pharmaceuticals, Inc.
Anne Bowdidge active positions
| Companies | Position | Start |
|---|---|---|
| ADICET BIO, INC. | Investor Relations Contact | - |
| AN2 THERAPEUTICS, INC. | Investor Relations Contact | - |
Former positions of Anne Bowdidge
| Companies | Position | End |
|---|---|---|
| MEDIVATION INC | Investor Relations Contact | 2017-01-31 |
| ANTHERA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| AN2 THERAPEUTICS, INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Anne Bowdidge
